Top news of the week: 14.04.2020.
Biotechnology, Health care, Antibody, Dot-com bubble, Clinical research, Medicine
Healthcare
More Coronavirus Vaccines and Treatments Move Toward Human Trials https://t.co/EhL6XEppiL https://t.co/JaZhXaiYM6
OpenMore Coronavirus Vaccine Efforts Move Toward Human Trials
Just three months after the start of the coronavirus pandemic, several biotech companies have shown promising vaccine programs and are beginning trials.
Deerfield Management Closes $840 Million Venture Capital Fund https://t.co/P59VWMJbyI https://t.co/i14AGxPJ5g
OpenDeerfield Management Closes $840 Million Venture Capital Fund
The fund will focus on investing in science startups related to new therapies and technology related to “improve the way healthcare is delivered to patients.”
Biopharma Update on the Novel Coronavirus: April 6 https://t.co/NI3s5nmReQ https://t.co/HtIsCpk4M1
OpenBiopharma Update on the Novel Coronavirus: April 6
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 6, 2020.
How China's Military Is Preparing for a 'New Domain of Warfare' #BioTech via https://t.co/2sI0UxJbpn https://t.co/bgz3x55HrQ
OpenWeaponizing Biotech: How China’s Military Is Preparing for a ‘New Domain of Warfare’
Under Beijing's civil-military fusion strategy, the PLA is sponsoring research on gene editing, human performance enhancement, and more.
The next instalment in @pharmaphorum's hugely popular COVID-19 webinar series with @IQVIA_UK looks at the disease's impacts for #pharma and #biotech in the UK and Ireland https://t.co/copC8Otx19 #coronavirus #COVD19 https://t.co/Q5N4uuICjI
OpenIQVIA COVID-19 April briefing: A deep dive on impacts for UK&I pharma + biotech
Overview This April webinar is part of IQVIA’s monthly updates on the impact of COVID-19 and its implications for the healthcare ecosystem. In the global effort to proactively fight ...
Biopharma Update on the Novel Coronavirus: April 8 https://t.co/gY2GnvnjGC https://t.co/PJ7gbvHgMp
OpenBiopharma Update on the Novel Coronavirus: April 8
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
venBio Closes $394 Million Life Sciences VC Fund https://t.co/aGTr2PAxIP https://t.co/ryA3cGHEn3
OpenvenBio Closes $394 Million Life Sciences VC Fund
The capital was raised from existing and new investors, including a broad range of institutional investors comprised of pharmaceutical companies, corporate pensions, financial institutions, ...
RT @Reuters: The anti-malaria drug hydroxychloroquine that President Trump has promoted as a potential weapon against COVID-19 has quickly become the standard way of treating patients. But doctors prescribing it tell @Reuters they have no idea whether it works https://t.co/YEh0jLckuz https://t.co/zFjPKkIzrh
OpenSpecial Report: Doctors embrace drug touted by Trump for COVID-19, without hard evidence it works
The decades-old drug that President Donald Trump has persistently promoted as a potential weapon against COVID-19 has within a matter of weeks become a standard of care in areas of the ...